LATEST

New research in hair growthMethod grows skin from pluripotent stem cells, supports hair follicle growth and may provide the opportunity to study skin growth and hair regeneration.
Laddered treatment for pityriasis rubra pilarisDiagnosing PRP is challenging because it can mimic eczema, psoriasis, or even ichthyosis. Biologic treatment for refractory cases considered, researchers said at AAD 2018.
Ustekinumab shows promise for reducing psoriasis-associated cardiovascular comorbidityInitial results of an investigator-initiated phase 4 trial suggest that blocking interleukin-12 (IL-12) and IL-23 may reduce cardiovascular inflammation associated with psoriasis, researchers reported at AAD 2018.
Methotrexate outperforms cyclosporine in atopic dermatitis studyThe duration of methotrexate administration proves to be longer than that of cyclosporine in atopic dermatitis, according to a small study that compared the two first-line immunosuppressive treatments for atopic dermatitis.
From new vaccines to the advent of new neurotoxinsPhysicians weigh in expectations for new developments within all facets of dermatology from pediatric dermatology to dermatopathology.
Biologics offer promise for hidradenitis suppurativa treatmentWith one approved biologic available and many more under investigation, the future of treatment for hidradenitis suppurativa looks very promising.
Up-and-coming fillers and neuromodulatorsInjectable aesthetic products recently FDA-approved or in late stages of development include polycaprolactone, a new hyaluronic acid and multiple neuromodulators.
Transgender careIncreasing dermatologists' cultural competence in this community can eliminate a barrier to care.
Strategic planningDermatologists must be aware of pending payment reductions and actively oppose Medicare's proposed elimination of global periods for certain procedures.
Switching biologic treatments in dermatologyNot all biologic treatments are equal. Side effects, effectiveness, cost and administration style are among factors physicians should consider when switching treatments, experts report at AAD 2018.

Poll

View Results